aspirin has been researched along with Carcinoma, Small Cell in 8 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Excerpt | Relevance | Reference |
---|---|---|
"A patient who had small cell lung cancer complicated by symmetrical peripheral gangrene, secondary to spontaneous platelet aggregation, improved dramatically after starting aspirin treatment." | 7.68 | Digital gangrene in small cell lung cancer: response to aspirin treatment. ( Arrowsmith, JE; Bevan, DH; Cummin, AR; Nanson, EM; Woodhead, MA, 1991) |
"A patient who had small cell lung cancer complicated by symmetrical peripheral gangrene, secondary to spontaneous platelet aggregation, improved dramatically after starting aspirin treatment." | 3.68 | Digital gangrene in small cell lung cancer: response to aspirin treatment. ( Arrowsmith, JE; Bevan, DH; Cummin, AR; Nanson, EM; Woodhead, MA, 1991) |
"To complete research in this type of coagulation and cancer, a multicentric randomized clinical trial was performed, including 303 patients with small cell lung cancer (SCLC), treated by the addition of aspirin at 1 g/day (a dosage at which aspirin is considered to be a platelet aggregation inhibitor) to combined chemotherapy." | 2.67 | No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group. ( Chastang, C; Fabre, C; Lebeau, B; Massin, F; Muir, JF; Vincent, J, 1993) |
"Risk of lung cancer was a non-significant 16% lower for regular aspirin users of one or two tablets per week and a significant 55% higher for users of 15 or more tablets per week compared with women who never regularly used aspirin." | 2.44 | Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. ( Bain, C; Chan, AT; Colditz, GA; Feskanich, D; Pandeya, N; Speizer, FE, 2007) |
" Although there was no clear evidence of a dose-response relationship, we observed risk reductions associated with greater frequency of use." | 1.31 | Regular aspirin use and lung cancer risk. ( Bepler, G; Cummings, KM; Falkner, KL; Loewen, GM; Menezes, RJ; Moysich, KB; Reid, ME; Ronsani, A; Swede, H, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
OchmaĆski, W | 1 |
Moysich, KB | 1 |
Menezes, RJ | 1 |
Ronsani, A | 1 |
Swede, H | 1 |
Reid, ME | 1 |
Cummings, KM | 1 |
Falkner, KL | 1 |
Loewen, GM | 1 |
Bepler, G | 1 |
Feskanich, D | 1 |
Bain, C | 1 |
Chan, AT | 1 |
Pandeya, N | 1 |
Speizer, FE | 1 |
Colditz, GA | 1 |
Lebeau, B | 2 |
Chastang, C | 1 |
Muir, JF | 1 |
Vincent, J | 1 |
Massin, F | 1 |
Fabre, C | 1 |
Akhmedkhanov, A | 1 |
Toniolo, P | 1 |
Zeleniuch-Jacquotte, A | 1 |
Koenig, KL | 1 |
Shore, RE | 1 |
Arrowsmith, JE | 1 |
Woodhead, MA | 1 |
Bevan, DH | 1 |
Nanson, EM | 1 |
Cummin, AR | 1 |
Lau, SS | 1 |
McMahon, JB | 1 |
McMenamin, MG | 1 |
Schuller, HM | 1 |
Boyd, MR | 1 |
1 review available for aspirin and Carcinoma, Small Cell
Article | Year |
---|---|
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ca | 2007 |
3 trials available for aspirin and Carcinoma, Small Cell
Article | Year |
---|---|
[Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy in patients with small cell lung cancer. Part I. Influence of AD on the haemostatic system].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Blood Coagulation; Carcinoma, | 2008 |
No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Small Cell; Cycloph | 1993 |
[Global approach to the treatment of small cell bronchial cancers].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, | 1987 |
4 other studies available for aspirin and Carcinoma, Small Cell
Article | Year |
---|---|
Regular aspirin use and lung cancer risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small C | 2002 |
Aspirin and lung cancer in women.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Non-Small-Cell Lung; Carci | 2002 |
Digital gangrene in small cell lung cancer: response to aspirin treatment.
Topics: Aspirin; Blood Platelet Disorders; Carcinoma, Small Cell; Fingers; Gangrene; Humans; Lung Neoplasms; | 1991 |
Metabolism of arachidonic acid in human lung cancer cell lines.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Arachidonic Acid; Arachidonic Acids; Aspirin; Calcimycin; Carci | 1987 |